Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer

被引:9
|
作者
Liang, Bin [1 ]
Shao, Yang [1 ]
Long, Fei [1 ]
Jiang, Shu-Juan [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
EXPRESSION; NETWORK; GEMCITABINE; PROTEINS; DATABASE; PATHWAY; RISK;
D O I
10.1155/2016/3952494
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lung cancer is the primary reason for death due to cancer worldwide, and non-small-cell lung cancer (NSCLC) is the most common subtype of lung cancer. Most patients die from complications of NSCLC due to poor diagnosis. In this paper, we aimed to predict gene biomarkers that may be of use for diagnosis of NSCLC by integrating differential gene expression analysis with functional association network analysis. We first constructed an NSCLC-specific functional association network by combining gene expression correlation with functional association. Then, we applied a network partition algorithm to divide the network into gene modules and identify the most NSCLC-specific gene modules based on their differential expression pattern in between normal and NSCLC samples. Finally, from these modules, we identified genes that exhibited the most impact on the expression of their functionally associated genes in between normal and NSCLC samples and predicted them as NSCLC biomarkers. Literature review of the top predicted gene biomarkers suggested that most of them were already considered critical for development of NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Non-small-cell lung cancer resectability: diagnostic value of PET/MR
    Fraioli, Francesco
    Screaton, Nicholas J.
    Janes, Samuel M.
    Win, Thida
    Menezes, Leon
    Kayani, Irfan
    Syed, Rizwan
    Zaccagna, Fulvio
    O'Meara, Celia
    Barnes, Anna
    Bomanji, Jamshed B.
    Punwani, Shonit
    Groves, Ashley M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (01) : 49 - 55
  • [42] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [43] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504
  • [44] Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
    Codony-Servat, Jordi
    Codony-Servat, Caries
    Cardona, Andres Felipe
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Berenguer, Ordi
    Paulina Bracht, Milan Wilhe Mina
    Ito, Masaoki
    Karachaliou, Niki
    Rosell, Rafael
    CLINICAL LUNG CANCER, 2019, 20 (03) : 167 - 177
  • [45] Advanced Non-Small-Cell Lung Cancer
    Kwon, Hyun W.
    Ham, Soo-Youn
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1997 - +
  • [46] Encephalitis in non-small-cell lung cancer
    Costa e Silva, M.
    Silva, E.
    Mendes, A.
    Barroso, A.
    PULMONOLOGY, 2021, 27 (06): : 582 - 583
  • [47] Immunotherapy of non-small-cell lung cancer
    Reinmuth, Niels
    Merk, Martina
    Duell, Thomas
    ONKOLOGE, 2021, 27 (02): : 179 - 190
  • [48] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [49] Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer
    Rosell, Rafael
    Karachaliou, Niki
    EBIOMEDICINE, 2018, 33 : 16 - 17
  • [50] Avelumab in non-small-cell lung cancer
    Rosell, Rafael
    Karachaliou, Niki
    LANCET ONCOLOGY, 2018, 19 (11): : 1423 - 1424